Related Experiment Video

Updated: May 14, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

Multifaceted hemolytic uremic syndrome in pediatrics

Carla M Nester1

  • 1Departments of Internal Medicine and Pediatrics, Rare Renal Disease Clinic, University of Iowa, Iowa City, IA 52242-1081, USA. carla-nester@uiowa.edu

Blood Purification
|January 25, 2013
PubMed

Insights

Diagnosing childhood hemolytic uremic syndromes (HUS) is challenging due to overlapping symptoms, delaying critical treatments. Promptly identifying the specific HUS cause is vital for effective management and improved patient outcomes.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Critical Care Medicine

Background:

  • Childhood hemolytic uremic syndromes (HUS) present with microangiopathic hemolytic anemia, thrombocytopenia, and renal injury.
  • Diagnostic confusion frequently arises due to overlapping clinical features.
  • Delayed diagnosis can impede timely initiation of renal-preserving and life-saving interventions.

Purpose of the Study:

  • To highlight the critical need for rapid and accurate diagnosis of HUS in children.
  • To emphasize the importance of differentiating HUS subtypes for appropriate treatment selection.
  • To underscore the impact of diagnosis on treatment strategies and patient prognosis.

Main Methods:

  • Review of clinical presentations and diagnostic challenges in pediatric HUS.
  • Analysis of the implications of diagnostic delays on patient management.
  • Discussion of the role of specific diagnostic criteria in guiding therapy.

Main Results:

  • Diagnostic uncertainty in HUS can lead to significant delays in treatment.
  • Treatment plans and prognoses vary considerably based on the specific HUS diagnosis.
  • The advent of anti-complement therapies necessitates precise etiological differentiation.

Conclusions:

  • Early and accurate diagnosis of HUS is paramount in pediatric care.
  • Consideration of all potential HUS syndromes at presentation is crucial.
  • A definitive diagnosis facilitates tailored treatment strategies for acute and long-term patient management.

More Related Videos

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...